GIONCO DAVID (Chief Accounting Officer) sold 4.2% of their position (13.86K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $69.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/13/2020ACC: 0001104659-20-033488
Officer· Chief Accounting Officer
Since Feb 2019
-13.86K
Net shares
Net seller
$69.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
13.86K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.01K
Price / share
$5.08
Trade value
$25.46K
% of position
1.5%
3/9/2020
333.59K→328.58K
Common Stock
Direct
Shares
−8.85K
Price / share
$4.92
Trade value
$43.52K
% of position
2.7%
3/10/2020
328.58K→319.73K
Total
Net shares
−13.86K
Net value
-$68.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2020 | S · Sale | −5.01K | $5.08 | $25.46K | 1.5% | 333.59K | 328.58K |
| Common Stock Direct | 3/10/2020 | S · Sale | −8.85K | $4.92 | $43.52K | 2.7% | 328.58K | 319.73K |
| Total | −13.86K | -$68.98K | ||||||
Derivative Transactions0
No derivative transactions reported